|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.00 USD | +20.00% |
|
+20.00% | - |
Company Valuation: American Oncology Network, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Market Cap 1 | - | - | 56.35 | 137.1 |
| Change | - | - | - | 143.33% |
| Enterprise Value (EV) | - | - | 125.3 | 215.2 |
| Change | - | - | - | 71.77% |
| P/E | - | - | -4.32x | -5.7x |
| PBR | - | - | -0.35x | -3.31x |
| PEG | - | - | - | 0.2x |
| Capitalization / Revenue | - | - | 0.04x | 0.08x |
| EV / Revenue | - | - | 0x | 0x |
| EV / EBITDA | - | - | -0x | -0x |
| EV / EBIT | - | - | -0x | -0x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | - | -1.365 | -0.8874 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 943.7 | 1,150 | 1,279 | 1,759 |
| EBITDA 1 | 6.99 | 12.28 | -4.668 | -5.575 |
| EBIT 1 | 0.911 | 5.566 | -13.12 | -16.09 |
| Net income 1 | -0.105 | 2.589 | -5.542 | -3.973 |
| Net Debt | 36.34 | 91.97 | 68.94 | 78.1 |
| Reference price 2 | 9.75 | 10.04 | 5.90 | 5.06 |
| Nbr of stocks (in thousands) | - | - | 9,550 | 27,096 |
| Announcement Date | 1/6/23 | 4/28/23 | 3/28/24 | 3/27/25 |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 405M | ||
| 16.67x | 0.46x | 10x | 2.55% | 133B | ||
| 13.47x | 1.74x | 8.58x | 0.76% | 90.2B | ||
| 12.72x | 1.45x | 8.79x | 2.67% | 27.41B | ||
| 21.58x | 2.35x | 11.87x | 1.57% | 22.96B | ||
| 29.06x | 5.35x | 22.59x | 2.4% | 19.9B | ||
| 8.11x | 1.27x | 5.99x | -.--% | 17.59B | ||
| 16.04x | 1.5x | 7.67x | 4.37% | 15.5B | ||
| 15.92x | 1.83x | 8.78x | 0.72% | 14.95B | ||
| 13.91x | 1.03x | 5.79x | 3.29% | 12.75B | ||
| Average | 16.39x | 1.89x | 10.01x | 2.04% | 35.46B | |
| Weighted average by Cap. | 15.98x | 1.42x | 9.87x | 1.94% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AONC Stock
- Valuation American Oncology Network, Inc.
Select your edition
All financial news and data tailored to specific country editions
















